By AMERICAN HEART ASSOCIATION NEWS

0331-News-New HBP treatment_BlogUnichem Pharmaceuticals, Inc., is voluntarily recalling one lot of Hydrochlorothiazide tablets after a different medication was found in a product bottle.

Hydrochlorothiazide — a diuretic or medication to get rid of excess body fluid — is used to manage high blood pressure and edema and are packaged in 1000-count bottles. The affected Hydrochlorothiazide tablets include Lot # GHYL15028 – Expiration April, 2018, which was distributed nationwide directly to wholesalers, retailers and pharmacies in May.

The misplaced tablet was Clopidogrel.

According to the Food and Drug Administration, “the risk associated with mistakenly taking a Clopidogrel tablet instead of a Hydrochlorothiazide tablet is the increased probability of experiencing Clopidogrel’s side effects which include bleeding and/or bruising. Patients with active bleeding or who are allergic to Clopidogrel or any component of the formulation may experience more serious adverse health consequences as a result of unknowingly consuming Clopidogrel. Additionally, missing a dose of Hydrochlorothiazide could result in uncontrolled blood pressure or swelling caused by excess fluid (edema).”

Unichem has not yet received any reports of adverse reactions related to the recall.